48,830
edits
m (→Overview) |
|||
Line 8: | Line 8: | ||
Types:<ref>STC. S.30-37, 19 Jan 2009.</ref> | Types:<ref>STC. S.30-37, 19 Jan 2009.</ref> | ||
*"Large cell dysplasia" (AKA ''large cell change'') - not considered a precursor for HCC, not considered a dysplasia.<ref name=pmid16982109>{{Cite journal | last1 = Park | first1 = YN. | last2 = Roncalli | first2 = M. | title = Large liver cell dysplasia: a controversial entity. | journal = J Hepatol | volume = 45 | issue = 5 | pages = 734-43 | month = Nov | year = 2006 | doi = 10.1016/j.jhep.2006.08.002 | PMID = 16982109 }}</ref> | *"Large cell dysplasia" (AKA ''large cell change'') - not considered a precursor for HCC, not considered a dysplasia.<ref name=pmid16982109>{{Cite journal | last1 = Park | first1 = YN. | last2 = Roncalli | first2 = M. | title = Large liver cell dysplasia: a controversial entity. | journal = J Hepatol | volume = 45 | issue = 5 | pages = 734-43 | month = Nov | year = 2006 | doi = 10.1016/j.jhep.2006.08.002 | PMID = 16982109 }}</ref> | ||
*Small cell dysplasia. | *[[Small liver cell dysplasia]] ([[AKA]] small cell dysplasia). | ||
*Low grade dysplasia. | *Low grade dysplasia. | ||
*High grade dysplasia. | *High grade dysplasia. | ||
===Neoplastic lesions=== | ===Neoplastic lesions=== | ||
*Hepatic adenoma. | *[[Hepatic adenoma]]. | ||
===Malignant lesions of the liver=== | ===Malignant lesions of the liver=== | ||
*Hepatocellular carcinoma (HCC) - most common malignant liver primary in adults. | *[[Hepatocellular carcinoma]] (HCC) - most common malignant liver primary in adults. | ||
*Hepatoblastoma - malignant liver primary in children. | *Hepatoblastoma - malignant liver primary in children. | ||
*Intrahepatic cholangiocarcinoma (ICC).<ref name=pmid19212669>{{Cite journal | last1 = Shirakawa | first1 = H. | last2 = Kuronuma | first2 = T. | last3 = Nishimura | first3 = Y. | last4 = Hasebe | first4 = T. | last5 = Nakano | first5 = M. | last6 = Gotohda | first6 = N. | last7 = Takahashi | first7 = S. | last8 = Nakagohri | first8 = T. | last9 = Konishi | first9 = M. | title = Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. | journal = Int J Oncol | volume = 34 | issue = 3 | pages = 649-56 | month = Mar | year = 2009 | doi = | PMID = 19212669 | url = http://www.spandidos-publications.com/serveFile/ijo_34_3_649_PDF.pdf?type=article&article_id=ijo_34_3_649&item=PDF}}</ref> | *Intrahepatic cholangiocarcinoma (ICC).<ref name=pmid19212669>{{Cite journal | last1 = Shirakawa | first1 = H. | last2 = Kuronuma | first2 = T. | last3 = Nishimura | first3 = Y. | last4 = Hasebe | first4 = T. | last5 = Nakano | first5 = M. | last6 = Gotohda | first6 = N. | last7 = Takahashi | first7 = S. | last8 = Nakagohri | first8 = T. | last9 = Konishi | first9 = M. | title = Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. | journal = Int J Oncol | volume = 34 | issue = 3 | pages = 649-56 | month = Mar | year = 2009 | doi = | PMID = 19212669 | url = http://www.spandidos-publications.com/serveFile/ijo_34_3_649_PDF.pdf?type=article&article_id=ijo_34_3_649&item=PDF}}</ref> | ||
Line 25: | Line 25: | ||
Features of HCC & its precursors - generated from DCHH<ref name=Ref_DCHH170-1>{{Ref DCHH|170-1}}</ref> and STC: | Features of HCC & its precursors - generated from DCHH<ref name=Ref_DCHH170-1>{{Ref DCHH|170-1}}</ref> and STC: | ||
{| class="wikitable" | {| class="wikitable" | ||
| '''Features''' || ''' | | '''Features''' || '''SLCD''' || '''Low-grade dysplasia''' || '''High-grade dysplasia''' || '''HCC''' | ||
|- | |- | ||
| Plate thickness || <3 cells || <=2 cells || <=3 cells, usu. >2 cells || '''>3 cells''' | | Plate thickness || <3 cells || <=2 cells || <=3 cells, usu. >2 cells || '''>3 cells''' | ||
Line 41: | Line 41: | ||
|} | |} | ||
Abbreviations: | Abbreviations: | ||
* | *SLCD = small liver cell dysplasia. | ||
Notes: | Notes: | ||
*Large cell dysplasia: | *Large cell dysplasia: | ||
**Cell size ~ 2x normal, [[NC ratio]] ~ normal. | **Cell size ~ 2x normal, [[NC ratio]] ~ normal. | ||
* | *SLCD: | ||
**Cell size ~ 1/2x normal, NC ratio - increased. | **Cell size ~ 1/2x normal, NC ratio - increased. | ||
edits